Full Text View
Tabular View
No Study Results Posted
Related Studies
Clarification of Optimal Anticoagulation Through Genetics (COAG)
This study is ongoing, but not recruiting participants.
Study NCT00839657   Information provided by National Heart, Lung, and Blood Institute (NHLBI)

First Received on February 6, 2009.   Last Updated on May 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stroke
Venous Thrombosis
Atrial Fibrillation
Atrial Flutter
Additional conditions recognized in this trial
Thrombosis
Venous Thromboembolism
More general conditions related to this trial
Arrhythmias, Cardiac
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Embolism and Thrombosis
Heart Diseases
Nervous System Diseases
Pathologic Processes
Thromboembolism
Vascular Diseases
Additional drug interventions recognized in this trial
Warfarin
More general drug interventions related to this trial
Anticoagulants
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Bristol-Myers Squibb


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services